Shareholders alert for AVI Biopharma Inc.

M2 PRESSWIRE-2 April 2007-Biotech News: Shareholders alert for AVI Biopharma Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:02042007 Shareholders alert for AVI Biopharma Inc (NASDAQ:AVII) AVI BioPharma, Inc., a biopharmaceutical company, engages in the development of therapeutic products based on NEUGENE antisense technology.

Its principal products in development target various diseases, including cardiovascular disease and infectious disease. The company's lead product candidate, Resten-NG, is a NEUGENE antisense drug for treating cardiovascular restenosis, or the renarrowing of ...

Read the rest of this article with a Free Trial at HighBeam Research.